Clinical Trials Logo
  1. Home
  2. Social Anxiety Disorder
  3. NCT05336552
  4. Details
NCT05336552 Clinical Trial

Social Anxiety Disorder in Medical Students in Sohag University

Social Anxiety Disorder Clinical Trial

— SAD-Med-Soh  

Official title:
Social Anxiety Disorder in Medical Students in Sohag University

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05336552
Other study ID # Soh-Med-22-04-13
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 23, 2022
Est. completion date June 2023

Study information
Verified date May 2022
Source Sohag University
Contact Mina Saad Louis, MBBS
Phone 01017844971
Email mena011203@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will be done in Sohag University to assess the prevalence and associated factors of Social Anxiety Disorder among undergraduate medical students .

Description:

Social anxiety disorder (SAD) is highly prevalent and it's the most common anxiety disorder among all types of anxiety disorders and the third most common psychiatric condition after major depression and alcohol dependence. Social anxiety disorder (SAD) is characterized by persistent fear/anxiety about one or more social or performance situations in social settings. SAD had a negative impact on learning ability, educational achievement, professional achievement, quality of life and social relationship & may lead to substance abuse and depressive disorders.

Recruitment information / eligibility
Status Recruiting
Enrollment 350
Est. completion date June 2023
Est. primary completion date May 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - Medical undergraduate students who are still studying for Bachelor of Medicine and Bachelor of Surgery ( M.B.B.Ch ) . Exclusion Criteria: - students who will refuse to participate in this study .

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Validated questionnaire : Social Phobia Inventory ( SPIN ) questionnaire
Social Phobia Inventory ( SPIN ) questionnaire which is consisted of 17 items. . The answers of each item ranged from 0 ( Not at all ) to 4 ( Extremely ). The total score will be calculated to determine the severity of the problem .

Locations
Country Name City State
Egypt Sohag university Sohag

Sponsors (1)
Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Social Phobia Inventory ( SPIN ) questionnaire Social Phobia Inventory ( SPIN ) questionnaire which is consisted of 17 items. The answers of each item ranged from 0 ( Not at all ) to 4 ( Extremely ).
The total score will be calculated to determine the severity of the problem as the following: - less than or equal 20 points means no disease, 21-30 means mild, 31-40 means moderate, 41-50 means severe , 51 or more means very severe.		 It will be measured after completion of the study , approximately in May 2023.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06274112 - Using TMS to Understand Neural Processes of Social Motivation N/A
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00684541 - Interpretation Modification Program for Social Phobia N/A
Completed NCT00684320 - Attention Disengagement Training for Social Phobia N/A
Completed NCT03247075 - Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT N/A
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Withdrawn NCT04622930 - Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD) N/A
Active, not recruiting NCT05018312 - Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Completed NCT05858294 - The Safety, Acceptability and Efficacy of Alena N/A
Active, not recruiting NCT05600114 - Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Not yet recruiting NCT02924610 - Brief Intervention to Reduce Fear Phase 4
Active, not recruiting NCT02592564 - Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder N/A
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Terminated NCT03764644 - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders N/A
Unknown status NCT01712321 - Study of Vilazodone to Treat Social Anxiety Disorder N/A
Completed NCT01320800 - CBT for Social Anxiety Disorder Delivered by School Counselors Phase 2
Completed NCT00485615 - An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia Phase 2
Completed NCT00773162 - Flushing in Social Anxiety Disorder on Seroquel Phase 3